Business Description
Medika DD
ISIN : HRMDKARA0000
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | 0.24 | |||||
Debt-to-Equity | 0.47 | |||||
Debt-to-EBITDA | 1.78 | |||||
Interest Coverage | 11.76 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.41 | |||||
Beneish M-Score | -2.3 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11 | |||||
3-Year EBITDA Growth Rate | 20.1 | |||||
3-Year EPS without NRI Growth Rate | 24.6 | |||||
3-Year FCF Growth Rate | 12 | |||||
3-Year Book Growth Rate | 13.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 32.95 | |||||
9-Day RSI | 39.77 | |||||
14-Day RSI | 42.27 | |||||
6-1 Month Momentum % | -14.62 | |||||
12-1 Month Momentum % | -20.71 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.13 | |||||
Quick Ratio | 0.89 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 39.33 | |||||
Days Sales Outstanding | 126.51 | |||||
Days Payable | 135.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.57 | |||||
Dividend Payout Ratio | 0.28 | |||||
3-Year Dividend Growth Rate | 7.1 | |||||
Forward Dividend Yield % | 3.57 | |||||
5-Year Yield-on-Cost % | 3.57 | |||||
3-Year Average Share Buyback Ratio | -2 | |||||
Shareholder Yield % | 13.63 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 7.76 | |||||
Operating Margin % | 2.82 | |||||
Net Margin % | 2.5 | |||||
FCF Margin % | 1.53 | |||||
ROE % | 18.78 | |||||
ROA % | 4.31 | |||||
ROIC % | 11.36 | |||||
ROC (Joel Greenblatt) % | 28.1 | |||||
ROCE % | 22.44 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 8.01 | |||||
PE Ratio without NRI | 7.95 | |||||
PEG Ratio | 0.34 | |||||
PS Ratio | 0.2 | |||||
PB Ratio | 1.36 | |||||
Price-to-Tangible-Book | 2.24 | |||||
Price-to-Free-Cash-Flow | 13.13 | |||||
Price-to-Operating-Cash-Flow | 8.78 | |||||
EV-to-EBIT | 7.97 | |||||
EV-to-EBITDA | 6.79 | |||||
EV-to-Revenue | 0.27 | |||||
EV-to-FCF | 17.39 | |||||
Price-to-Peter-Lynch-Fair-Value | 336.13 | |||||
Price-to-Graham-Number | 0.89 | |||||
Price-to-Net-Current-Asset-Value | 4.91 | |||||
Earnings Yield (Greenblatt) % | 12.55 | |||||
FCF Yield % | 7.63 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Medika DD Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 811.071 | ||
EPS (TTM) (€) | 698.83 | ||
Beta | 0 | ||
Volatility % | 15.25 | ||
14-Day RSI | 42.27 | ||
14-Day ATR (€) | 43.734747 | ||
20-Day SMA (€) | 5697.5 | ||
12-1 Month Momentum % | -20.71 | ||
52-Week Range (€) | 5550 - 7700 | ||
Shares Outstanding (Mil) | 0.03 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Medika DD Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Medika DD Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Medika DD Frequently Asked Questions
What is Medika DD(ZAG:MDKA)'s stock price today?
When is next earnings date of Medika DD(ZAG:MDKA)?
Does Medika DD(ZAG:MDKA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |